Group 1 - The National Medical Products Administration (NMPA) has accepted the application for the injection of Lidasibep by PCI San Diego, with acceptance number JTS2600031, on February 28, 2026 [1] - The drug Lidasibep is classified as a biological product and is under the import registration application type [1] - The company involved, Haisen Biopharmaceutical Co., Ltd., was established on September 16, 2020, and operates in the chemical pharmaceutical raw materials manufacturing industry [1] Group 2 - Haisen Biopharmaceutical Co., Ltd. is a small-sized limited liability company with a registered capital of 352,331.6667 million RMB and has 49 insured employees [1] - The sole shareholder of Haisen Biopharmaceutical is Haisen Biopharmaceutical (Hong Kong) Holdings Co., Ltd., which holds 100% of the shares [1] - The registered address of Haisen Biopharmaceutical is located at No. 99, Shanshui Road, Dianbu Town, Feidong County, Hefei City, Anhui Province [1]
药物受理最新动态：PCI San Diego莱达西贝普注射液进口申请获受理
Xin Lang Cai Jing·2026-02-27 23:23